Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Not Applicable

Completed

• Conditions: Venous Thromboembolism
• Interventions: Behavioral: electronic alerts

• Registration Number: NCT01598805
• Lead Sponsor: University of Zurich

Brief Summary

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

Detailed Description

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Study Timeline

• Study First Submitted: 2012-05-11
• Study First Submitted QC: 2012-05-14
• Study First Posted: 2012-05-15
• Study Start: 2012-06
• Primary Completion: 2012-09
• Study Completion: 2012-09
• Status Verified: 2012-11
• Last Update Submitted: 2012-11-15
• Last Update Posted: 2012-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
roll out of eAlerts	electronic alerts	Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Primary Outcome Measures

Name	Time	Method
Rate of prophylaxis against venous thromboembolism	3 months	patients with prophylaxis/total patients

Secondary Outcome Measures

Name	Time	Method
ordering time after admission or transfer of a patient	3 months	time when physicians order a venous thromboembolism prophylaxis
acceptance of the eAlerts	3 months	survey of compliant and incompliant physicians

Trial Locations

Locations (1)

University Hospital Zurich, Center for Clinical Research; 🇨🇭 Zurich, Switzerland